AzTrials
AzTrials

Central Nervous System Complications of AnesthesiaEGAINNCT02182817

Exposure to General Anaesthesia in Infancy and Neurocognitive Development

An observational study of Central Nervous System Complications of Anesthesia and Impaired Cognition, run by KK Women's and Children's Hospital at 2 sites in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This prospective cohort study aims to determine if apparently healthy children with no significant co-morbidities who undergo general anaesthesia for minor surgery before 15 months of age will develop measurable deficits in neurocognitive development compared to apparently healthy children with no significant… Read more about this study

Who is it for?
Ages 1 day to 15 monthsHealthy volunteers can take part
How many people
250 participants
Where
2 sitesSingapore
Study dates
Nov 2013to Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 15 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Full-term infants with no significant co-morbidities presenting for minor surgery at KK Womens' and children's hospital, Singapore

Who may be able to join

  • Infants born > 36 weeks gestation
  • No significant co-morbidities
  • Who undergo general sevoflurane anaesthesia for minor surgery lasting <150 minutes (including herniotomies, orchidopexies, circumcisions and pyloromyotomies) before 15 months of age

Who cannot join

  • Prematurity <36 weeks gestation
  • Birth weight less than 2400g
  • Presence of a genetic or chromosomal disorder
  • Disorder of the central nervous system, including any seizure disorder
  • Major congenital cardiac defects

Trial locations and contacts

2 sites in 1 country.

Singapore2 sites
  • Singapore Institute of Clinical Sciences

    Singapore, 117609

  • KK Women's and Children's Hospital. 100 Bukit Timah Road

    Singapore, 229899

Other trials in Singapore

About this study

Official title: Prospective Cohort Study of Effects of Exposure to General Anaesthesia in Infancy on Neurocognitive Development

This prospective cohort study aims to determine if apparently healthy children with no significant co-morbidities who undergo general anaesthesia for minor surgery before 15 months of age will develop measurable deficits in neurocognitive development compared to apparently healthy children with no significant co-morbidities who do not undergo general anaesthesia or surgery.

Read the detailed description

We hypothesize that healthy children exposed to general anaesthesia for minor surgery before 15 months of age will have significantly lower neurocognitive scores at 6,18, 24 and 36 months of age compared with age, and gender matched healthy children from the GUSTO cohort without prior exposure to general anaesthesia or surgery. (GUSTO: Growing Up Towards Healthy Outcomes in Singapore: a prospective longitudinal study providing normative data from the local population).

Keywords
General Anaesthesia, Neurocognitive Development, Behaviour
Medical subject headings
Cognition Disorders, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02182817
Study groupRoleWhat they receive
GA-Exposed GroupExposure to general anaesthesia below 15 months of age
Unexposed GroupChildren not exposed to general anaesthesia or surgery from GUSTO cohort. (GUSTO: Growing Up Towards Healthy Outcomes in Singapore: a prospective longitudinal study providing normative data from the local population)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurocognitive Assessment: Bayley's Scale of Infant Development-III

    Bayley's Scale of Infant Development-III

    Measured: 24 months of age

Secondary outcomes (5)
  1. Neurocognitive Assessment: Deferred Imitation

    Deferred imitation is used to assess declarative memory

    Measured: 6 and 18 months of age

  2. Neurocognitive Assessment: Habituation

    Determines if an infant shows 'novelty preference' when stimuli are shown repeatedly.

    Measured: 6 and 18 months of age

  3. Behavioural Assessment: Child behaviour checklist

    Measured: 24 months of age

  4. Event Related Potential

    Auditory Oddball

    Measured: 6 and 18 months of age

  5. Visual Expectation

    Measured: 6 and 18 months of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2014 (estimated)
  2. Study startNov 2013
  3. Primary completionJul 2019
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02182817
Sponsor's protocol ID
EGAIN 2013/552/D
Acronym
EGAIN
Status last verified
Jan 2021
First submitted
10 Jun 2014
Last updated
21 Feb 2021
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Central Nervous System Complications of Anesthesia and Impaired Cognition, run by KK Women's and Children's Hospital at 2 sites in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurocognitive Assessment: Bayley's Scale of Infant Development-III (time frame: 24 months of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in